We and others have shown that TERT promoter mutations, causing hyperactivation of telomerase, are highly frequent in HPV-related cancers and HCV-related hepatocellular carcinoma [28,31,32,135,171]. This evidence concerns the gene TERT and hepatocellular carcinoma.